Oncology Innovative Products
Wembrace Biopharma offers a broad range of Oncology pharmaceuticals and nutraceuticals backed by continuous research and innovation. Our portfolio includes solid and liquid orals, syrups, suspensions, chewable tablets, hard and soft capsules, lyophilised lipid suspensions, and ready-to-use injectable formulations and introduction of the latest interventions related to the prevention and management of the chemotherapy and radiotherapy-induced oral mucositis. We focus on clinical efficacy, safety, and product stability to support better patient outcomes. As an emerging Oncology leader, we are committed to making advanced, accessible cancer care a reality. With our vision “Smile with Miles,” we strive to bring hope and improved quality of life to patients.
Wembrace Biopharma Pvt Ltd
| Brand Name | Molecule | Therapy | Dosage Form | Packing | Description | Package Insert |
|---|---|---|---|---|---|---|
| DOCISOL 20MG /80MG | Nanosomal Docetaxel lipid Suspension | Anti-neoplastic | Vial | 1x20mg, 1X80mg |
DOCISOL 20MG /80MG Nanosomal Docetaxel Lipid Suspension Anti-Neoplastic Vial 1x20mg, 1X80mg Docisol 20mg/80mg Injection is an anti-cancer medication used for the treatment of breast cancer, non-small cell lung cancer, prostate cancer and cancers of head and neck. Docetaxel is a second-generation chemotherapeutic agent of the taxane family. docetaxel’s primary mechanism of action is to bind β-tubulin, enhancing proliferation and stabilizing conformation. Doing so inhibits the proper assembly of microtubules into the mitotic spindle, arresting the cell cycling during G2/M Some of the common side effects of this medicine include breathlessness, constipation, oedema (swelling), infection, loss of appetite, muscle pain, nail disorder, pain, and weakness. | Download PDF |
| XELODACE DT 1GM /500MG | Capecitabine | Anti-neoplastic | Dispersible Tablet | 1X10’s |
Xelodace DT 1MG Tablet is used in the treatment of cancer of the breast, colon, rectum, Pancreatic adenocarcinoma, stomach, oesophageal, gastro-oesophageal cancer. Capecitabine is a type of chemotherapy called an anti metabolite. The body changes capecitabine into a common chemotherapy drug called fluorouracil. It stops cells making and repairing DNA. Cancer cells need to make and repair DNA so they can grow and multiply | Download PDF |
| WEMBIRA DT 250MG | Abiraterone acetate | Anti-neoplastic | Dispersible Tablet | 1X10’s |
Wembira DT 250 MG, Abiraterone Acetate is an anticancer medication. It works by preventing androgen (a male hormone) production in men. This is done by inhibiting an enzyme (CYP17) that is responsible for the production of androgen. | Download PDF |
| ABRA ACE 100 MG | (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) | Anti-neoplastic | Vial | 1X100mg |
Abraace 100MG Injection is an anti-cancer medication that may be used in combination with other medicines. Abraace is a microtubule inhibitor. It is used for the treatment of breast cancer, pancreatic cancer and non-small cell lung cancer in adults. Some common side effects of this medicine include nausea, vomiting, diarrhoea, and weakness. | Download PDF |
| LEVISCD2 | Levilactobacillus brevis CD2 | Probiotic | Lozenges | 1X20’s |
Levis CD2 lozenges contains L. brevisCD2 not less than 2 X109 (2 billion) viable cells of L. brevis CD2 as the active ingredient. Lactobacillus brevis, L. brevis CD2, produces high levels of arginine deiminase and sphingomyelinase. Reduces in the levels of some of inflammatory parameters (cytokines IL-1a, IL-6,IL-8, TNF-a, IFN-y, PGE2 and matrix metalloproteinases). Bacterial sphingomyelinase can hydrolyse the platelet-activating factor (PAF). | Download PDF |
